-
公开(公告)号:US20050164362A1
公开(公告)日:2005-07-28
申请号:US10872770
申请日:2004-06-21
申请人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Megan Domagala , Simon Houston , Matthew Kimber , Benjamin Pinder , Francois Vallee , Olga Wrezel , Donald Awrey , Bryan Beattie
发明人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Megan Domagala , Simon Houston , Matthew Kimber , Benjamin Pinder , Francois Vallee , Olga Wrezel , Donald Awrey , Bryan Beattie
CPC分类号: C12N9/18 , C07K14/21 , C07K2299/00
摘要: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
-
公开(公告)号:US20050239186A1
公开(公告)日:2005-10-27
申请号:US11047365
申请日:2005-01-31
申请人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Matthew Kimber
发明人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Matthew Kimber
CPC分类号: C12Q1/18 , C07K2299/00 , C07K2319/00 , C12N9/18 , C12Q1/34 , G01N2333/315 , G01N2333/918 , G01N2500/04
摘要: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译: 本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号:US20060003432A1
公开(公告)日:2006-01-05
申请号:US11047383
申请日:2005-01-31
申请人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Teresa Clarke , Matthew Kimber
发明人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Teresa Clarke , Matthew Kimber
CPC分类号: C12N9/93 , C07K2299/00 , C12Q1/18 , C12Q1/25 , G01N2500/00
摘要: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译: 本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号:US20050181388A1
公开(公告)日:2005-08-18
申请号:US10958216
申请日:2004-10-04
申请人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Cheryl Arrowsmith , Donald Awrey , Bryan Beattie , Kristina Buzadzija , Veronica Canadien , Megan Domagala , Simon Houston , Dhushy Kanagarajah , Qin Li , Kamran Mansoury , Merry-Lynn McDonald , Kathleen Nethery-Brokx , Ivy Ng , Hui Ouyang , Benjamin Pinder , Dawn Richards , Matthew Tai , Rosanne Thalakada , Francois Vallee , Cristina Virag
发明人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Cheryl Arrowsmith , Donald Awrey , Bryan Beattie , Kristina Buzadzija , Veronica Canadien , Megan Domagala , Simon Houston , Dhushy Kanagarajah , Qin Li , Kamran Mansoury , Merry-Lynn McDonald , Kathleen Nethery-Brokx , Ivy Ng , Hui Ouyang , Benjamin Pinder , Dawn Richards , Matthew Tai , Rosanne Thalakada , Francois Vallee , Cristina Virag
IPC分类号: C07K14/245 , C07K14/315 , C07K14/32 , C12N9/00 , C12N9/02 , C12N9/04 , C12N9/10 , C12N9/12 , C12N9/14 , C12N9/16 , C12N9/78 , C12N9/90 , C12Q1/68 , G01N33/00
CPC分类号: C12N9/0008 , C07K14/245 , C07K14/3156 , C07K14/32 , C07K2319/00 , C12N9/0006 , C12N9/1007 , C12N9/1077 , C12N9/1085 , C12N9/1205 , C12N9/1229 , C12N9/1235 , C12N9/1241 , C12N9/14 , C12N9/16 , C12N9/78 , C12N9/90 , C12N9/93 , C12Y101/01158 , C12Y102/01011 , C12Y201/01033 , C12Y201/01045 , C12Y201/01061 , C12Y204/02007 , C12Y205/01007 , C12Y207/01026 , C12Y207/01048 , C12Y207/04008 , C12Y207/06001 , C12Y207/07003 , C12Y207/07023 , C12Y207/07038 , C12Y304/11018 , C12Y304/24057 , C12Y305/04005 , C12Y306/01001 , C12Y501/03001 , C12Y504/02003 , C12Y599/01003 , C12Y601/01014 , C12Y601/0102 , C12Y601/01021 , C12Y603/02004 , C12Y603/02008 , C12Y603/02013 , C12Y603/04014 , C12Y604/01002
摘要: The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
-
公开(公告)号:US20050181464A1
公开(公告)日:2005-08-18
申请号:US10953901
申请日:2004-09-29
申请人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Cheryl Arrowsmith , Donald Awrey , Bryan Beattie , Kristina Buzadzija , Teresa Clarke , Megan Domagala , Simon Houston , Dhushy Kanagarajah , Qin Li , Kamran Mansoury , Merry-Lynn McDonald , Kathleen Nethery-Brokx , Ivy Ng , Hui Ouyang , Dawn Richards , Francois Vallee , Cristina Virag
发明人: Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Cheryl Arrowsmith , Donald Awrey , Bryan Beattie , Kristina Buzadzija , Teresa Clarke , Megan Domagala , Simon Houston , Dhushy Kanagarajah , Qin Li , Kamran Mansoury , Merry-Lynn McDonald , Kathleen Nethery-Brokx , Ivy Ng , Hui Ouyang , Dawn Richards , Francois Vallee , Cristina Virag
IPC分类号: B01D15/38 , C07K14/205 , C07K14/21 , C07K14/245 , C07K14/31 , C07K14/315 , C12N1/06 , C12N9/00 , C12N9/02 , C12N9/04 , C12N9/06 , C12N9/10 , C12N9/12 , C12N9/48 , C12N9/78 , C12N9/88 , C12N9/90 , G01N33/554 , C07K14/195 , G01N33/00 , G01N33/569
CPC分类号: C12N9/0016 , B01D15/3804 , C07K14/205 , C07K14/21 , C07K14/245 , C07K14/31 , C07K14/315 , C07K14/3156 , C12N1/06 , C12N9/0006 , C12N9/0008 , C12N9/1022 , C12N9/1029 , C12N9/1205 , C12N9/1247 , C12N9/1252 , C12N9/1288 , C12N9/48 , C12N9/78 , C12N9/88 , C12N9/90 , C12N9/93
摘要: The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
-
公开(公告)号:US07601526B2
公开(公告)日:2009-10-13
申请号:US11647506
申请日:2006-12-28
申请人: Judd M. Berman , Molly B. Schmid , Donald E. Awrey , Teresa Clarke , Bryan Beattie , Mandy Dorsey
发明人: Judd M. Berman , Molly B. Schmid , Donald E. Awrey , Teresa Clarke , Bryan Beattie , Mandy Dorsey
CPC分类号: C07K14/195 , C07K2299/00
摘要: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein derived from Fransicella tularensis comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译: 本发明涉及病原菌的新型药物靶标。 因此,本发明提供了从包含SEQ ID NO:2所示氨基酸序列的土拉氏弗斯兰氏菌得到的纯化蛋白质。本发明还提供了本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号:US20080108793A1
公开(公告)日:2008-05-08
申请号:US11647506
申请日:2006-12-28
申请人: Judd M. Berman , Molly B. Schmid , Donald E. Awrey , Teresa Clarke McGrath , Bryan Beattie , Mandy Dorsey
发明人: Judd M. Berman , Molly B. Schmid , Donald E. Awrey , Teresa Clarke McGrath , Bryan Beattie , Mandy Dorsey
IPC分类号: C07K14/195 , G01N33/569 , C07K16/00
CPC分类号: C07K14/195 , C07K2299/00
摘要: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译: 本发明涉及病原菌的新型药物靶标。 因此,本发明提供了包含SEQ ID NO:2所示的氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
-
-
-
-
-